Terms: = Leukemia AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Clinical Outcome
6 results:
1. 5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.
Díaz-Santa J; Rodríguez-Romanos R; Coll R; Osca G; Pratcorona M; González-Bártulos M; Garrido A; Angona A; Talarn C; Tormo M; Arnan M; Vives S; Salamero O; Tuset E; Lloveras N; Díez I; Zamora L; Bargay J; Sampol A; Cruz D; Vila J; Sitges M; Garcia A; Vall-Llovera F; Esteve J; Sierra J; Gallardo D;
Eur J Haematol; 2022 Dec; 109(6):755-764. PubMed ID: 36063368
[TBL] [Abstract] [Full Text] [Related]
2. A deconvolution method and its application in analyzing the cellular fractions in acute myeloid leukemia samples.
Li H; Sharma A; Ming W; Sun X; Liu H
BMC Genomics; 2020 Sep; 21(1):652. PubMed ID: 32967610
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.
Mitra AK; Crews KR; Pounds S; Cao X; Feldberg T; Ghodke Y; Gandhi V; Plunkett W; Dolan ME; Hartford C; Raimondi S; Campana D; Downing J; Rubnitz JE; Ribeiro RC; Lamba JK
J Pharmacol Exp Ther; 2011 Oct; 339(1):9-23. PubMed ID: 21712425
[TBL] [Abstract] [Full Text] [Related]
4. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic value of cn-ii and cn-iiI enzymes in adult acute myeloid leukemia.
Galmarini CM; Cros E; Thomas X; Jordheim L; Dumontet C
Haematologica; 2005 Dec; 90(12):1699-701. PubMed ID: 16330448
[TBL] [Abstract] [Full Text] [Related]
6. Deoxycytidine kinase and cn-ii nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.
Galmarini CM; Thomas X; Graham K; El Jafaari A; Cros E; Jordheim L; Mackey JR; Dumontet C
Br J Haematol; 2003 Jul; 122(1):53-60. PubMed ID: 12823345
[TBL] [Abstract] [Full Text] [Related]
